Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-2-induced lymphoproliferative responses.

A Winkelstein1, L D Weaver, N Salva

  • 1Department of Medicine, Montefiore Hospital, University of Pittsburgh School of Medicine, Pa. 15213.

Cancer Immunology, Immunotherapy : CII
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relation of gastric acidity to recurrent ulcers after partial gastrectomy.

The Journal of the International College of Surgeons·2010
Same author

The prophylaxis of peptic ulcer.

Gastroenterology·2010
Same author

Modern treatment of gastric ulcer.

Strasbourg medical·2010
Same author

The significance of the gastric acidity in the surgical therapy of peptic ulcer.

The Surgical clinics of North America·2010
Same author

The Modern Treatment of Peptic Ulcer.

Bulletin of the New York Academy of Medicine·2009
Same author

Immunohematologic disorders.

JAMA·1997

Interleukin-2 (IL-2) concentration dictates immune cell expansion. Higher IL-2 doses promote CD8+ T cell and CD3+ CD56+ cytotoxic cell growth, while lower doses favor CD4+ T cells.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Interleukin-2 (IL-2) is known to stimulate immune responses, including lymphoproliferation and cytotoxicity.
  • Conflicting reports exist regarding the specific immune cell phenotypes that respond to IL-2 stimulation.

Purpose of the Study:

  • To investigate the impact of varying Interleukin-2 (IL-2) concentrations on the phenotypes of peripheral blood mononuclear cells (PBMCs).
  • To clarify the cell populations responsible for IL-2-mediated immune modulation.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) were isolated using Ficoll/Hypaque density gradient centrifugation.
  • PBMCs were cultured with different concentrations of IL-2 (50, 100, or 1000 U/ml) for 1, 3, and 5 weeks.
  • Flow cytometry was used to analyze the expression of cell surface markers (CD3, CD4, CD8, CD56, CD16) to determine cell phenotypes.

Related Experiment Videos

Main Results:

  • All IL-2 concentrations progressively increased CD3+ T cells, exceeding 90% by 3-5 weeks.
  • Lower IL-2 concentrations (50-100 U/ml) preferentially expanded CD4+ T cells.
  • Higher IL-2 concentration (1000 U/ml) led to a predominance of CD8+ T cells, increasing from 28% to 51% within 3 weeks.
  • High-dose IL-2 (1000 U/ml) significantly increased CD56+ cells, mainly the CD3+ CD56+ cytotoxic T cell subset.
  • Natural killer (NK) cells (CD16+) declined across all IL-2 concentrations.

Conclusions:

  • The concentration of IL-2 critically influences the expansion of specific immune cell subsets.
  • High-dose IL-2 promotes the development of CD8+ cytotoxic T cells and CD3+ CD56+ cells.
  • The findings clarify the distinct cellular responses to varying IL-2 levels, impacting immune modulation strategies.